[IgA pemphigus accompanying multiple myeloma].
Veselý
K
K
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001897:Boronic Acids / Q000008:administration & dosage; D000069286:Bortezomib; D003520:Cyclophosphamide / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D006801:Humans; D007070:Immunoglobulin A / Q000097:blood*; D009101:Multiple Myeloma / Q000150:complications*; D010265:Paraproteinemias / Q000150:complications; D010392:Pemphigus / Q000150:complications* / Q000276:immunology*; D061988:Proteasome Inhibitors; D011719:Pyrazines / Q000008:administration & dosage
D001897:Boronic Acids; D007070:Immunoglobulin A; D061988:Proteasome Inhibitors; D011719:Pyrazines; D000069286:Bortezomib; D003907:Dexamethasone; D003520:Cyclophosphamide